13F HOLDINGS REPORT
DCVC Opportunity Fund II GP, LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001104659-25-111912
Total Value
$19.3M
Positions
1
Other Managers
0
Confidential Omitted
No
Holdings (1)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Recursion Pharmaceuticals, Inc. | RXRX | 3,951,141 | $19.3M | 100.00% |